Literature DB >> 28653180

Regional interaction between myocardial sympathetic denervation, contractile dysfunction, and fibrosis in heart failure with preserved ejection fraction: 11C-hydroxyephedrine PET study.

Tadao Aikawa1, Masanao Naya2, Masahiko Obara1, Noriko Oyama-Manabe3, Osamu Manabe4, Keiichi Magota5, Yoichi M Ito6, Chietsugu Katoh7, Nagara Tamaki8.   

Abstract

PURPOSE: This investigation aimed to identify significant predictors of regional sympathetic denervation quantified by 11C-hydroxyephedrine (HED) positron emission tomography (PET) in patients with heart failure with preserved left ventricular ejection fraction (HFpEF).
METHODS: Included in the study were 34 patients (age 63 ± 15 years, 23 men) with HFpEF (left ventricular ejection fraction ≥40%) and 11 age-matched volunteers without heart failure. Cardiac magnetic resonance imaging was performed to measure left ventricular size and function, and the extent of myocardial late gadolinium enhancement (LGE). 11C-HED PET was performed to quantify myocardial sympathetic innervation that was expressed as a 11C-HED retention index (RI, %/min). To identify predictors of regional 11C-HED RI in HFpEF patients, we propose a multivariate mixed-effects model for repeated measures over segments with an unstructured covariance matrix.
RESULTS: Global 11C-HED RI was significantly lower and more heterogeneous in HFpEF patients than in volunteers (P < 0.01 for all). Regional 11C-HED RI was correlated positively with systolic wall thickening (r = 0.42, P < 0.001) and negatively with the extent of LGE (r = -0.43, P < 0.001). Segments in HFpEF patients with a large extent of LGE had the lowest regional 11C-HED RI among all segments (P < 0.001 in post hoc tests). Multivariate analysis demonstrated that systolic wall thickening and the extent of LGE were significant predictors of regional 11C-HED RI in HFpEF patients (both P ≤ 0.001).
CONCLUSION: Regional sympathetic denervation was associated with contractile dysfunction and fibrotic burden in HFpEF patients, suggesting that regional sympathetic denervation may provide an integrated measure of myocardial damage in HFpEF.

Entities:  

Keywords:  11C-Hydroxyephedrine; Contractile dysfunction; Heart failure with preserved ejection fraction; Myocardial fibrosis; Regional sympathetic denervation

Mesh:

Substances:

Year:  2017        PMID: 28653180     DOI: 10.1007/s00259-017-3760-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  29 in total

1.  Multiparametric molecular imaging provides mechanistic insights into sympathetic innervation impairment in the viable infarct border zone.

Authors:  Riikka Lautamaki; Tetsuo Sasano; Takahiro Higuchi; Stephan G Nekolla; Albert C Lardo; Daniel P Holt; Robert F Dannals; M Roselle Abraham; Frank M Bengel
Journal:  J Nucl Med       Date:  2015-01-29       Impact factor: 10.057

2.  Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.

Authors:  Karl-Philipp Rommel; Maximilian von Roeder; Konrad Latuscynski; Christian Oberueck; Stephan Blazek; Karl Fengler; Christian Besler; Marcus Sandri; Christian Lücke; Matthias Gutberlet; Axel Linke; Gerhard Schuler; Philipp Lurz
Journal:  J Am Coll Cardiol       Date:  2016-04-19       Impact factor: 24.094

3.  Impaired Myocardial Sympathetic Innervation Is Associated with Diastolic Dysfunction in Heart Failure with Preserved Ejection Fraction: 11C-Hydroxyephedrine PET Study.

Authors:  Tadao Aikawa; Masanao Naya; Masahiko Obara; Osamu Manabe; Yuuki Tomiyama; Keiichi Magota; Satoshi Yamada; Chietsugu Katoh; Nagara Tamaki; Hiroyuki Tsutsui
Journal:  J Nucl Med       Date:  2016-11-03       Impact factor: 10.057

4.  Identification and further differentiation of subendocardial and transmural myocardial infarction by fast strain-encoded (SENC) magnetic resonance imaging at 3.0 Tesla.

Authors:  Noriko Oyama-Manabe; Naoki Ishimori; Hiroyuki Sugimori; Marc Van Cauteren; Kohsuke Kudo; Osamu Manabe; Tomoyuki Okuaki; Tamotsu Kamishima; Yoichi M Ito; Hiroyuki Tsutsui; Khin Khin Tha; Satoshi Terae; Hiroki Shirato
Journal:  Eur Radiol       Date:  2011-06-18       Impact factor: 5.315

5.  Relationship between altered sympathetic innervation, oxidative metabolism and contractile function in the cardiomyopathic human heart; a non-invasive study using positron emission tomography.

Authors:  F M Bengel; B Permanetter; M Ungerer; S G Nekolla; M Schwaiger
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

6.  Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography.

Authors:  F Hartmann; S Ziegler; S Nekolla; M Hadamitzky; M Seyfarth; G Richardt; M Schwaiger
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

7.  Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.

Authors:  E B Henderson; J K Kahn; J R Corbett; D E Jansen; J J Pippin; P Kulkarni; V Ugolini; M S Akers; C Hansen; L M Buja
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

8.  The significance of cardiac sympathetic nervous system abnormality in the long-term prognosis of patients with a history of ventricular tachyarrhythmia.

Authors:  Yasushi Akutsu; Kyouichi Kaneko; Yusuke Kodama; Hui-Ling Li; Mitsuharu Kawamura; Taku Asano; Kaoru Tanno; Akira Shinozuka; Takehiko Gokan; Youichi Kobayashi
Journal:  J Nucl Med       Date:  2008-12-17       Impact factor: 10.057

9.  Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.

Authors:  Hidenobu Terai; Masami Shimizu; Hidekazu Ino; Masato Yamaguchi; Katsuharu Uchiyama; Kotaro Oe; Kenichi Nakajima; Junichi Taki; Masaya Kawano; Hiroshi Mabuchi
Journal:  J Nucl Med       Date:  2003-10       Impact factor: 10.057

10.  Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing.

Authors:  Jeanette Schulz-Menger; David A Bluemke; Jens Bremerich; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Raymond J Kim; Florian von Knobelsdorff-Brenkenhoff; Christopher M Kramer; Dudley J Pennell; Sven Plein; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2013-05-01       Impact factor: 5.364

View more
  3 in total

1.  Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter.

Authors:  Xinyu Chen; Alexander Fritz; Rudolf A Werner; Naoko Nose; Yusuke Yagi; Hiroyuki Kimura; Steven P Rowe; Kazuhiro Koshino; Michael Decker; Takahiro Higuchi
Journal:  Mol Imaging Biol       Date:  2020-06       Impact factor: 3.488

Review 2.  Advanced imaging for risk stratification for ventricular arrhythmias and sudden cardiac death.

Authors:  Eric Xie; Eric Sung; Elie Saad; Natalia Trayanova; Katherine C Wu; Jonathan Chrispin
Journal:  Front Cardiovasc Med       Date:  2022-08-22

3.  Sympathetic nerve innervation and metabolism in ischemic myocardium in response to remote ischemic perconditioning.

Authors:  Attila Kiss; Ping Wu; Michaela Schlederer; Patrick M Pilz; Petra Lujza Szabo; Jingle Li; Lukas Weber; Chrysoula Vraka; Verena Pichler; Markus Mitterhauser; Xiaoli Zhang; Karin Zins; Dietmar Abraham; Sijin Li; Bruno K Podesser; Marcus Hacker; Xiang Li
Journal:  Basic Res Cardiol       Date:  2022-08-25       Impact factor: 12.416

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.